 3. Failure of at least one anti-arrhythmic medication AAD for paroxysmal atrial fibrillation class I or III, or AV nodal blocking agents such as beta blockers BB and calcium channel blockers CCB as evidenced by recurrent symptomatic paroxysmal atrial fibrillation, or intolerable side effects due to AAD. 